Iquest KRX:262840KOSDAQ

아이퀘스트 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days1
Articles tracked4since Sep 11

In Q3 2026, Iquest reported revenue of ₩10.6bn, down 9.7% year on year, and operating profit of ₩919m. Iquest (아이퀘스트) appeared in 1 Korean news article and 1 DART filing over the past seven days. Coverage peaked on Nov 13 with 1 article.

Filing signals Buyback Cancellation Screener

Iquest quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩10.6bn-9.7%₩919m
margin 8.6%
₩232m
Q2 2026₩10.3bn-2.0%₩870m
margin 8.4%
₩1.1bn
Q1 2026₩10.5bn+7.6%₩634m
margin 6.0%
₩5.8bn
Q4 2025 derived₩11.4bn+1.6%₩1.3bn
margin 11.2%
₩2.0bn
Q3 2025₩11.8bn+3.9%₩926m
margin 7.9%
₩776m
Q2 2025₩10.6bn+21.3%₩1.0bn
margin 9.8%
₩799m
Q1 2025₩9.8bn+4.7%₩1.0bn
margin 10.5%
₩2.4bn
Q4 2024 derived₩11.3bn+0.2%₩1.9bn
margin 16.8%
₩2.2bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Iquest top stories 2 weeks, by number of outlets

  1. 1
    iQuest third quarter cumulative net profit up 79%, expands shareholder returns
    1 outlets · 1 articlesFirst report Nov 13 11:39 이데일리

Latest Iquest news Korean headlines